2014年全球銷售額將逼近1500億美元

　　根據全球50家大型制藥企業的所有重磅生物制藥（銷售超過10億美元的產品）建模推算，2013年全球重磅生物制藥總銷售額達1420億美元，年增長率為9.1%，預計2014年全球銷售額將逼近1500億美元。重磅生物制藥行業的市場前景頗為樂觀，研究人士表示，“現有產品遠遠不能充滿整個市場空間”。在國內，生物醫藥產業也正風生水起，多地紛紛加快發展生物醫藥產業的步伐。據預計，在未來三年內，中國生物產業產值的年增長率將高達20%，在相關領域的投資額將超過3000億美元，而該領域也將成為利潤豐厚的投資領域之一。

　　由歐洲博聞展覽咨詢有限公司(UBM Live)和中國醫藥保健品進出口商會主辦，上海博華國際展覽有限公司（UBM Sinoexpo） 協辦的2015生物制藥與技術中國展(BioPh China 2015) 將在2015年6月24-26日在上海新國際博覽中心舉行。

　　生物技術與制藥中國展契合生物制藥行業蓬勃發展的趨勢，聚焦生物科技、臨床試驗，集中展示基因工程、抗體工程、細胞培養、生物儀器等產品與技術，為制藥制藥公司、新藥研發企業及專業人士提供最佳的貿易交流平臺，助力生物制藥市場的無限商機。甘李藥業、長春金賽、沈陽三生、東寶實業、深圳邁高、廈門特寶等知名企業將作為展商參與本次展會。

　　2015第二屆Bioph中國生物制藥峰會將與生物制藥中國展同期舉辦，聚集來自生物醫藥、生物科技、權威法規部門、風險投資等相關領域頂尖專家，聚焦國內法規更新、全球市場機遇與挑戰以及技術優化與創新三大板塊與主題，深入解讀最新注冊與審批政策，探討全球市場融合下的創新合作模式、優化關鍵技術加速產業化進程等熱點內容，致力于為行業從業者提供一個分享研發經驗和案例分析的絕佳平臺，通過促進交流與合作，充分挖掘中國生物制藥市場的無限可能。

　　2015生物制藥中國展將進一步加強與海外醫藥企業間的溝通與合作，培育品牌、提升技術、構建渠道，為全面推動中國生物制藥行業發展做出更大的貢獻。

　　It is estimated that the total sales of blockbuster biologics of global top 50 pharmaceutical companies has reached 140 billion US dollars, with a yearly growth rate of 9.1%. 2014 is expected to approach 150 billion US dollars. The global biopharmaceutical market sees a rosy prospect. Researchers suggested that the existing products are far from the whole market capacity. In China, the biopharmaceutical industry is also developing at an accelerated pace. China’s growth rate of bio-industry output value is estimated to reach 20% within three years. Investment in related fields will exceed 300 billion US dollars.Biopharma will also become one of the highest profit industries.

　　BioPhExpo China 2015, organized by UBM Live and CCCMHPIE and supported by UBM Sinoexpo, will be held on 24-26 June 2015 in Shanghai New International Expo Centre.

　　BioPhExpo China focuses on biotechnology and related fields offering an ideal platform for biopharma companies, drug discovery organizations, pharma manufacturers and scientific research institutions to create new partnerships and discuss the latest topics. All companies and organizations dealing with the research and development of new treatment methods made through biotechnological processes or which are derived from or use live organisms benefited from the exhibition. Well-known enterprises like Gan&Lee,GeneScience, Sunshine, Dongbao, Mellow Hope,Amoytop, etc. will attend this event as exhibitors.

　　2015 BioPh Summit China, concurrent with BioPh Expo, will bring together top experts and scientists from biopharma, biotechs, legislation, venture capital, etc. as well as leading technology solution providers from all over Asia and the rest of the world. Topics cover the latest regulations, current global biopharma market conditions ,opportunities and challenges, and crucial aspects of biopharma technology in China. It provides a platform to share research developments, case studies, best practices and discuss the challenges regarding the biopharmaceutical industry to unlock the potential of the huge market.

　　BioPh Expo China 2015 will continue to further improve the relationship with overseas pharmaceutical enterprises in brand building, technique promotion and channel construction for China’s biopharmaceutical industry development.